Appointed
Joseph Haniford
Director
TG ·
TREDEGAR CORP
the Board elected Joseph Haniford as a director of the Company, effective immediately.
Ready 8-Ks
22
Latest filing
May 27, 2026, 4:28 PM ET
Top materiality
0.85
Event mix
earnings ×8 · leadership ×7 · other_material ×2
Sentiment
7 pos · 3 neg · 12 neu
Latest earnings
reported 2026-Q1
Executive change
recent →
Recent 8-K filings for TG
Highest-materiality recent filing
Brazilian competition authority approves Tredegar's sale of Terphane to Oben Group; closing expected Nov 1
- Brazil's CADE approved a merger control agreement on Oct 16, 2024, allowing Tredegar to sell Terphane to Oben Group.
- Base consideration for Terphane is $116 million net cash-free and debt-free.
-
Tredegar directors Freeman and Tack resign after failing re-election; Haniford appointed
George C. Freeman, III and Carl E. Tack, III failed to win majority votes at 2026 annual meeting; resigned effective May 22, 2026.
-
Tredegar annual meeting: say-on-pay proposal fails, strong opposition to three directors
Say-on-pay advisory vote received only 56.9% support: 15.9M for, 12.0M against, 18k abstentions.
-
Tredegar Q1 net income from continuing ops $5.1M ($0.15/diluted), up from $0.7M YoY
Net income from continuing operations $5.1M ($0.15 diluted EPS) vs $0.7M ($0.02) in Q1 2025.
-
Tredegar Q4 net income $14.5M vs $7.3M loss; Aluminum Extrusions EBITDA up 61% YoY
Q4 ongoing EPS $0.32 vs $0.06; full-year ongoing EPS $0.74 vs $0.50.
-
Tredegar appoints David Parks to board; director Newsome to retire at 2026 annual meeting
David Parks elected independent director effective February 3, 2026; board size increased from seven to eight.
-
Paul Goldschmiedt appointed Controller effective January 1, 2026; will serve as principal accounting officer.
-
Tredegar discloses compensation for new CEO ($625k base) and CFO ($400k base), effective Jan 1, 2026
CEO DasGupta: $625k base salary, target short-term incentive 100% of base, max 200%.
-
Tredegar announces CEO and CFO retirements, names internal successors effective Jan 1, 2026
CEO John Steitz to retire Dec 31, 2025; Arijit DasGupta elected President and CEO effective Jan 1, 2026.
-
Tredegar Q3 2025 net income $7.1M vs year-ago loss of $3.4M
Net income from continuing operations $7.1M ($0.20/diluted share) compared to $(3.4)M ($(0.10)/share) in Q3 2024.
-
Tredegar CFO D. Andrew Edwards to retire effective Dec 31, 2025
D. Andrew Edwards, CFO & EVP, to retire on December 31, 2025.
-
Tredegar Q2 net income drops 80% to $1.8M; Aluminum Extrusions EBITDA falls 28% on tariff headwinds
Net income from continuing ops $1.8M ($0.05/diluted) vs $9.2M ($0.27) in Q2 2024; ongoing EPS $0.05 vs $0.30.
-
Tredegar shareholders elect all director nominees, approve say-on-pay and auditor ratification
All six director nominees elected: top vote-getter Christine Vlahcevic with 25.8M for vs 0.97M against.
-
Tredegar amends ABL facility: $125M, maturity extended to 2030, rates reduced
New $125M asset-based facility; maturity extended from 202X to May 6, 2030.
-
Tredegar Q1 net income falls to $0.7M; Aluminum Extrusions EBITDA down 27% YoY
GAAP net income from continuing ops $0.7M ($0.02/sh) vs $2.6M ($0.08/sh) Q1 2024.
-
Tredegar narrows Q4 net loss to $7.3M; ongoing EPS $0.06; both segments show EBITDA growth
Q4 2024 net loss from continuing ops $(7.3)M ($(0.21)/diluted) vs $(34.1)M ($(1.00)) in Q4 2023.
-
Tredegar appoints Christine Vlahcevic as independent director, board expands to seven
Board increased from six to seven members effective January 9, 2025.
-
Tredegar Q3 2024 break-even ongoing ops; completes Terphane sale for $78M enterprise value
Q3 2024 net income from ongoing ops $0.2M ($0.01/share) vs loss of $5.1M ($0.15) in Q3 2023.
-
Tredegar completes sale of Terphane to Oben Group for $116M; expects $85M net proceeds
Sale closed Nov 1, 2024; total cash-free, debt-free base consideration of $116 million.
-
Brazil's CADE approved a merger control agreement on Oct 16, 2024, allowing Tredegar to sell Terphane to Oben Group.
-
Tredegar swings to Q2 profit of $0.26/share vs loss of $0.56 YoY; segment EBITDA improves
Net income $8.8M ($0.26 diluted) vs loss $18.9M ($0.56) in Q2 2023.
-
Tredegar Updates on Brazilian Merger Review for Terphane Sale to Oben Group
SG-CADE issued a non-binding opinion on May 13, 2024 recommending rejection of the Terphane sale to Oben Group.
-
Tredegar shareholders reelect all directors; say-on-pay passes with 39% dissent
All six director nominees elected; George C. Freeman III received 13.9M for and 12.8M against (48% against).
Executive changes
Departed
George C. Freeman, III
Director
TG ·
TREDEGAR CORP
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
Departed
Carl E. Tack, III
Director
TG ·
TREDEGAR CORP
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
Appointed
Christine R. Vlahcevic
Director
TG ·
TREDEGAR CORP
On January 9, 2025, the Board of Directors (the “Board”) of Tredegar Corporation (the “Company”) increased the size of the Board from six to seven and elected Christine R. Vlahcevic as director of the Company, in each case, effective immediately.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.60 · Most common event earnings